A 2016 systematic review published in The Cochrane Database of Systematic Reviews (PMID: 27479272) evaluated the efficacy and safety of bioidentical hormone therapy (BHT) for menopausal vasomotor symptoms. Analyzing randomized controlled trials comparing BHT to placebo or conventional hormone therapy, the study found that 17β-estradiol effectively reduced the frequency and
